Yentl Van Rymenant

Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics

Marcel Martin, Sanjana Ballal, Madhav Prasad Yadav et al. · Cancers · 2023 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn’s disease

Bo-Jun Ke, Saeed Abdurahiman, Francesca Biscu et al. · Journal of Clinical Investigation · 2024 · 45 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.

Euy Sung Moon, Madhav P. Yadav, Chandrasekhar Bal et al. · PubMed · 2021 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA5.SA.FAPi and DOTA.SA.FAPi

Euy Sung Moon, Yentl Van Rymenant, Sandeep Battan et al. · Molecules · 2021 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes

Yentl Van Rymenant, Muhammet Tanç, Roos Van Elzen et al. · Frontiers in Chemistry · 2021 · 21 citations · Full text

Medicine, Biochemistry, Molecular Biology +13